Group 1 - The company has a total of 397 patents as of the end of 2024, with 30 of these patents related to the nephrology medical sector [1] - The German subsidiary remains a wholly-owned subsidiary of the company, and any temporary information disclosure will be conducted in accordance with legal and regulatory requirements [1]